 CARLSBAD, Calif., Dec. 2, 2020 PRNewswire -- Qualigen Therapeutics, Inc. Nasdaq: QLGN announces that it has completed the recertification of its supply of AS1411, and has begun final formulation and filling for use in the Companys proposed Phase 2a efficacy trials of AS1411 for the... 